Skip to main content
. 2011 Jun 23;8(6):2533–2555. doi: 10.3390/ijerph8062533

Table 2.

Activity of Vernonia amygdalina Del. extract, fractions, Epivernodalol and doxorubicin against HT-144 (skin melanoma) cell line.

Code GI50 (μg/mL) TGI (μg/mL) LC50 (μg/mL)
MEVA (extract) 86 ± 1.3 141.3 ± 4.7 199 ± 10.8
VAD (fraction) 3.3 ± 0.3** 6.3 ± 0.3** 10.6 ± 0.8**
VAP (fraction) 9.7 ± 2.3* 21.2 ± 5.4* 37.7 ± 4.4*
Epivernodalol 1.76 ± 0.3** 7.33 ± 0.55** 22 ± 1.2**
Doxorubicin 0.01 ± 0 0.07 ± 0.03 0.48 ± 0.1

Each value represents the means ± SD of three independent experiments.

*

Significantly different from MEVA (p < 0.05).

**

Significantly different from MEVA (p < 0.01). GI50 = Growth inhibition of 50% of the cells; TGI = Total growth inhibition. LC50 = Lethal concentration of the compound/extract that kills 50% of the cells. MEVA: methanolic extract of Vernonia amygdalina; VAP: petroleum ether fraction; VAD: dichloromethane fraction. (Adapted from Owoeye et al. [37]).